Status:
UNKNOWN
mNGS Was Applied to the Study of Pathogen Identification, Precision Medication and Efficacy Evaluation of Infected Patients
Lead Sponsor:
Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine
Conditions:
mNGS
Eligibility:
All Genders
18-75 years
Phase:
NA
Brief Summary
1\) prospectively collected the patients with the proposed infection, confirmed the infection or excluded the infection through mNGS detection combined with traditional pathogen detection methods and ...
Eligibility Criteria
Inclusion
- 18 to 75 years old
- expected length of stay in ICU was \> 24 h
- suspected infected patients (PSI or CPIS, qSOFA or SIRS)
Exclusion
- Pregnant and lactating women
- Who has not signed the informed consent
- the researchers considered that others were not suitable for the study
Key Trial Info
Start Date :
October 1 2020
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
September 30 2023
Estimated Enrollment :
200 Patients enrolled
Trial Details
Trial ID
NCT04310657
Start Date
October 1 2020
End Date
September 30 2023
Last Update
March 17 2020
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.